| Thomas H Magee, MD | |
|
709 S Harbor City Blvd Ste 100, Melbourne, FL 32901-1968 | |
| (321) 409-9900 | |
| (321) 309-9033 |
| Full Name | Thomas H Magee |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 38 Years |
| Location | 709 S Harbor City Blvd Ste 100, Melbourne, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033226204 | NPI | - | NPPES |
| 1033226204 | Medicaid | IA | |
| 262084700 | Medicaid | FL | |
| 102220848 0001 | Medicaid | PA | |
| 0157392 00 | Medicaid | MD | |
| 232300 | Medicaid | AZ | |
| 8495293 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 72043 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Florida Radiology Llc | 1850627811 | 4 |
| Neuroskeletal Imaging Llc | 6204865223 | 7 |
News Archive
From medicine and food to energy and agriculture, bio-based innovations are in great demand, providing new solutions to the challenges faced by societies in the 21st century. New innovations in plant biotechnology, such as the development of gluten-free wheat, could bring hope to those suffering from Celiac disease. On a global scale, as the world population nears seven billion people, biotechnology plays an increasing role in plant health and thereby, human food supplies.
Multidisciplinary project from Alicante University (UA) Artefactos recently validated the emergency "Skuba" mask for healthcare use. In light of the infection speed of the COVID-19 virus and the lack of certified protective equipment, at Artefactos they have developed and manufactured an emergency breathing mask by adapting a commercial snorkel mask.
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification by the FDA that the Company's proprietary device, HydroFix™ Vaso Shield, has received 510(k) clearance for additional thicknesses and sizes.
Mylan N.V., today announced the U.S. launch of Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP, 1 mg / 0.05 mg. Mylan's product was determined to be bioequivalent and, therefore, therapeutically equivalent to the reference listed drug, Zovia® 1/50E-28 Tablets (Watson).
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it held a pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of Montelukast Sodium Oral Soluble Film (OSF) under a 505(b)(2) pathway.
› Verified 9 days ago
| Entity Name | Manatee Diagnostic Center Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689760993 PECOS PAC ID: 2264489293 Enrollment ID: O20050401000606 |
News Archive
From medicine and food to energy and agriculture, bio-based innovations are in great demand, providing new solutions to the challenges faced by societies in the 21st century. New innovations in plant biotechnology, such as the development of gluten-free wheat, could bring hope to those suffering from Celiac disease. On a global scale, as the world population nears seven billion people, biotechnology plays an increasing role in plant health and thereby, human food supplies.
Multidisciplinary project from Alicante University (UA) Artefactos recently validated the emergency "Skuba" mask for healthcare use. In light of the infection speed of the COVID-19 virus and the lack of certified protective equipment, at Artefactos they have developed and manufactured an emergency breathing mask by adapting a commercial snorkel mask.
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification by the FDA that the Company's proprietary device, HydroFix™ Vaso Shield, has received 510(k) clearance for additional thicknesses and sizes.
Mylan N.V., today announced the U.S. launch of Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP, 1 mg / 0.05 mg. Mylan's product was determined to be bioequivalent and, therefore, therapeutically equivalent to the reference listed drug, Zovia® 1/50E-28 Tablets (Watson).
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it held a pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of Montelukast Sodium Oral Soluble Film (OSF) under a 505(b)(2) pathway.
› Verified 9 days ago
| Entity Name | Neuroskeletal Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639163975 PECOS PAC ID: 6204865223 Enrollment ID: O20050810000711 |
News Archive
From medicine and food to energy and agriculture, bio-based innovations are in great demand, providing new solutions to the challenges faced by societies in the 21st century. New innovations in plant biotechnology, such as the development of gluten-free wheat, could bring hope to those suffering from Celiac disease. On a global scale, as the world population nears seven billion people, biotechnology plays an increasing role in plant health and thereby, human food supplies.
Multidisciplinary project from Alicante University (UA) Artefactos recently validated the emergency "Skuba" mask for healthcare use. In light of the infection speed of the COVID-19 virus and the lack of certified protective equipment, at Artefactos they have developed and manufactured an emergency breathing mask by adapting a commercial snorkel mask.
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification by the FDA that the Company's proprietary device, HydroFix™ Vaso Shield, has received 510(k) clearance for additional thicknesses and sizes.
Mylan N.V., today announced the U.S. launch of Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP, 1 mg / 0.05 mg. Mylan's product was determined to be bioequivalent and, therefore, therapeutically equivalent to the reference listed drug, Zovia® 1/50E-28 Tablets (Watson).
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it held a pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of Montelukast Sodium Oral Soluble Film (OSF) under a 505(b)(2) pathway.
› Verified 9 days ago
| Entity Name | Central Florida Radiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225592041 PECOS PAC ID: 1850627811 Enrollment ID: O20190729002462 |
News Archive
From medicine and food to energy and agriculture, bio-based innovations are in great demand, providing new solutions to the challenges faced by societies in the 21st century. New innovations in plant biotechnology, such as the development of gluten-free wheat, could bring hope to those suffering from Celiac disease. On a global scale, as the world population nears seven billion people, biotechnology plays an increasing role in plant health and thereby, human food supplies.
Multidisciplinary project from Alicante University (UA) Artefactos recently validated the emergency "Skuba" mask for healthcare use. In light of the infection speed of the COVID-19 virus and the lack of certified protective equipment, at Artefactos they have developed and manufactured an emergency breathing mask by adapting a commercial snorkel mask.
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification by the FDA that the Company's proprietary device, HydroFix™ Vaso Shield, has received 510(k) clearance for additional thicknesses and sizes.
Mylan N.V., today announced the U.S. launch of Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP, 1 mg / 0.05 mg. Mylan's product was determined to be bioequivalent and, therefore, therapeutically equivalent to the reference listed drug, Zovia® 1/50E-28 Tablets (Watson).
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it held a pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of Montelukast Sodium Oral Soluble Film (OSF) under a 505(b)(2) pathway.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas H Magee, MD Po Box 400, Melbourne, FL 32902 Ph: (321) 409-9990 | Thomas H Magee, MD 709 S Harbor City Blvd Ste 100, Melbourne, FL 32901-1968 Ph: (321) 409-9900 |
News Archive
From medicine and food to energy and agriculture, bio-based innovations are in great demand, providing new solutions to the challenges faced by societies in the 21st century. New innovations in plant biotechnology, such as the development of gluten-free wheat, could bring hope to those suffering from Celiac disease. On a global scale, as the world population nears seven billion people, biotechnology plays an increasing role in plant health and thereby, human food supplies.
Multidisciplinary project from Alicante University (UA) Artefactos recently validated the emergency "Skuba" mask for healthcare use. In light of the infection speed of the COVID-19 virus and the lack of certified protective equipment, at Artefactos they have developed and manufactured an emergency breathing mask by adapting a commercial snorkel mask.
MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification by the FDA that the Company's proprietary device, HydroFix™ Vaso Shield, has received 510(k) clearance for additional thicknesses and sizes.
Mylan N.V., today announced the U.S. launch of Ethynodiol Diacetate and Ethinyl Estradiol Tablets USP, 1 mg / 0.05 mg. Mylan's product was determined to be bioequivalent and, therefore, therapeutically equivalent to the reference listed drug, Zovia® 1/50E-28 Tablets (Watson).
MonoSol Rx, the developers of PharmFilm® technology and a drug delivery company specializing in proprietary pharmaceutical film products, today announced that it held a pre-investigational new drug (IND) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of Montelukast Sodium Oral Soluble Film (OSF) under a 505(b)(2) pathway.
› Verified 9 days ago
David Samuel Epstein, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1775 W Hibiscus Blvd, Ste 215, Melbourne, FL 32901 Phone: 321-837-3820 | |
Dr. Irina S Mezheritskiy, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1350 S Hickory St, Holmes Regional Medical Center/radiology, Melbourne, FL 32901 Phone: 321-434-7313 Fax: 321-434-7238 | |
Dr. Charles Ehlenberger, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1350 Hickory Street, Melbourne, FL 32901 Phone: 321-434-7000 | |
Dr. Santiago Jimenez, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1223 Gateway Dr, Melbourne, FL 32901 Phone: 321-549-0677 | |
Steven D Picerne, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1800 W Hibiscus Blvd Ste 100, Melbourne, FL 32901 Phone: 321-726-3800 | |
Dr. Brent D Brandon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1350 S Hickory St, Holmes Regional Medical Center/radiology, Melbourne, FL 32901 Phone: 321-434-7313 Fax: 321-434-7238 |